BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1450412)

  • 1. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
    Olopade OI; Thangavelu M; Larson RA; Mick R; Kowal-Vern A; Schumacher HR; Le Beau MM; Vardiman JW; Rowley JD
    Blood; 1992 Dec; 80(11):2873-82. PubMed ID: 1450412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
    Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
    Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivative (1;7)(q10;p10) in a patient with de novo acute erythroblastic leukemia (AML-M6).
    Obara N; Shinagawa A; Komatsu T; Abe T; Ninomiya H
    Cancer Genet Cytogenet; 1999 Nov; 115(1):62-4. PubMed ID: 10565302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemia.
    Fitzgerald PH; Morris CM; Fraser GJ; Giles LM; Hamer JW; Heaton DC; Beard ME
    Cancer Genet Cytogenet; 1983 Jan; 8(1):51-66. PubMed ID: 6572548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial acute myeloid leukemia and DiGuglielmo syndrome.
    Siebert R; Jhanwar S; Brown K; Berman E; Offit K
    Leukemia; 1995 Jun; 9(6):1091-4. PubMed ID: 7596175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
    Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
    Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19.
    Cigudosa JC; Odero MD; Calasanz MJ; Solé F; Salido M; Arranz E; Martínez-Ramirez A; Urioste M; Alvarez S; Cervera JV; MacGrogan D; Sanz MA; Nimer SD; Benitez J
    Genes Chromosomes Cancer; 2003 Apr; 36(4):406-12. PubMed ID: 12619165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.
    Schoch C; Schnittger S; Klaus M; Kern W; Hiddemann W; Haferlach T
    Blood; 2003 Oct; 102(7):2395-402. PubMed ID: 12805060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
    Goldberg SL; Noel P; Klumpp TR; Dewald GW
    Am J Clin Oncol; 1998 Feb; 21(1):42-7. PubMed ID: 9499256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and cytogenetic features of familial erythroleukaemia.
    Lee EJ; Schiffer CA; Misawa S; Testa JR
    Br J Haematol; 1987 Mar; 65(3):313-20. PubMed ID: 3471269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.
    Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Van Orshoven A; Criel A; Stul M; Dal Cin P; Hernandez J
    Blood; 1995 Jun; 85(12):3688-94. PubMed ID: 7780152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features.
    Fagioli F; Cuneo A; Carli MG; Bardi A; Piva N; Previati R; Rigolin GM; Ferrari L; Spanedda R; Castoldi G
    Cancer Genet Cytogenet; 1993 Dec; 71(2):119-24. PubMed ID: 7506635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia.
    Crane MM; Strom SS; Halabi S; Berman EL; Fueger JJ; Spitz MR; Keating MJ
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):639-44. PubMed ID: 8824367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant and reactive erythroblasts in erythroleukemia (M6).
    Bernheim A; Berger R; Daniel MT; Valensi F; Flandrin G
    Cancer Genet Cytogenet; 1983 Sep; 10(1):1-10. PubMed ID: 6576849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomes and causation of human cancer and leukemia. LIII. Comprehensive cytogenetic analysis of an erythroleukemia.
    Gibas Z; Becher R; Sandberg AA
    Cancer Genet Cytogenet; 1983 Nov; 10(3):241-53. PubMed ID: 6578871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.